Mendus
4.06 SEK
-5.58 %
Less than 1K followers
IMMU
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Mendus
EV/S
Median 2019-2022
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 193.79 | 136.32 | 78.94 | 44.40 | 10.46 | 7.80 | 5.60 |
| Shares | 5.0 | 9.0 | 10.8 | 10.8 | 43.2 | 50.4 | 62.6 |
| Market cap | 970.5 | 1,229.6 | 854.4 | 480.6 | 451.4 | 392.9 | 350.5 |
| Enterprise value | 673.7 | 1,063.2 | 699.4 | 464.8 | 354.3 | 312.8 | - |
| EV/S | 754.5 | - | 22,562.2 | 137.5 | - | - | - |
| EV/EBITDA | neg. | neg. | neg. | neg. | neg. | neg. | - |
| EV/EBIT | neg. | neg. | neg. | neg. | neg. | neg. | - |
| P/E | neg. | neg. | neg. | neg. | neg. | neg. | neg. |
| P/B | 3.56 | 1.86 | 1.30 | 0.93 | 0.64 | 0.61 | 0.60 |
| P/S | 1,086.8 | - | 27,562.4 | 142.2 | - | - | - |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 89.8 % | 90.7 % | 91.1 % | 82.9 % | 93.2 % | 92.6 % | 93.1 % |
| Gearing ratio | - | 0.2 % | 0.0 % | 5.1 % | 3.4 % | 3.4 % | 3.1 % |